Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher R Chapple

Showing results (111-120 of 271) with videos related to

Pageof 28
Sort By:
Nature Reviews. Urology|July 6, 2011
The placebo effect in overactive bladder syndromeAltaf Mangera, Christopher R Chapple, Zoe S Kopp, et al.
Neurourology and Urodynamics|November 1, 2011
Are biomechanical properties predictive of the success of prostheses used in stress urinary incontinence and pelvic organ prolapse? A systematic reviewAltaf Mangera, Anthony J Bullock, Christopher R Chapple, et al.
European Urology Focus|July 30, 2017
Oestradiol-releasing Biodegradable Mesh Stimulates Collagen Production and Angiogenesis: An Approach to Improving Biomaterial Integration in Pelvic Floor RepairNaşide Mangır, Christopher J Hillary, Christopher R Chapple, et al.
European Urology|July 17, 2013
Mesh sling in an era of uncertainty: lessons learned and the way forwardChristopher R Chapple, Shlomo Raz, Linda Brubaker, et al.
Current Opinion in Urology|June 18, 2003
Recent developments in the management of detrusor overactivityVivek Kumar, Lucy Templeman, Christopher R Chapple, et al.
European Urology|June 2, 2009
European Association of Urology position statement on screening for prostate cancerPer-Anders Abrahamsson, Walter Artibani, Christopher R Chapple, et al.
World Journal of Urology|August 20, 2011
Urinary urgency: a review of its assessment as the key symptom of the overactive bladder syndromePaul Abrams, Christopher R Chapple, Klaus-Peter Jünemann, et al.
The Urologic Clinics of North America|August 1, 2016
Antimuscarinics, β-3 Agonists, and Phosphodiesterase Inhibitors in the Treatment of Male Lower Urinary Tract Symptoms: An Evolving ParadigmNadir I Osman, Reem Aldamanhori, Altaf Mangera, et al.
The Journal of Urology|December 18, 2001
The role of M2 muscarinic receptor subtypes in mediating contraction of the pig bladder base after cyclic adenosine monophosphate elevation and/or selective M3 inactivationTomonori Yamanishi, Christopher R Chapple, Kosaku Yasuda, et al.
Current Opinion in Urology|May 4, 2011
The afferent system and its role in lower urinary tract dysfunctionDonna M Daly, Valerie M Collins, Christopher R Chapple, et al.
Pageof 28

Showing results (111-120 of 271) with videos related to

Sort By:
Pageof 28
Nature Reviews. Urology|July 6, 2011
The placebo effect in overactive bladder syndromeAltaf Mangera, Christopher R Chapple, Zoe S Kopp, et al.
Neurourology and Urodynamics|November 1, 2011
Are biomechanical properties predictive of the success of prostheses used in stress urinary incontinence and pelvic organ prolapse? A systematic reviewAltaf Mangera, Anthony J Bullock, Christopher R Chapple, et al.
European Urology Focus|July 30, 2017
Oestradiol-releasing Biodegradable Mesh Stimulates Collagen Production and Angiogenesis: An Approach to Improving Biomaterial Integration in Pelvic Floor RepairNaşide Mangır, Christopher J Hillary, Christopher R Chapple, et al.
European Urology|July 17, 2013
Mesh sling in an era of uncertainty: lessons learned and the way forwardChristopher R Chapple, Shlomo Raz, Linda Brubaker, et al.
Current Opinion in Urology|June 18, 2003
Recent developments in the management of detrusor overactivityVivek Kumar, Lucy Templeman, Christopher R Chapple, et al.
European Urology|June 2, 2009
European Association of Urology position statement on screening for prostate cancerPer-Anders Abrahamsson, Walter Artibani, Christopher R Chapple, et al.
World Journal of Urology|August 20, 2011
Urinary urgency: a review of its assessment as the key symptom of the overactive bladder syndromePaul Abrams, Christopher R Chapple, Klaus-Peter Jünemann, et al.
The Urologic Clinics of North America|August 1, 2016
Antimuscarinics, β-3 Agonists, and Phosphodiesterase Inhibitors in the Treatment of Male Lower Urinary Tract Symptoms: An Evolving ParadigmNadir I Osman, Reem Aldamanhori, Altaf Mangera, et al.
The Journal of Urology|December 18, 2001
The role of M2 muscarinic receptor subtypes in mediating contraction of the pig bladder base after cyclic adenosine monophosphate elevation and/or selective M3 inactivationTomonori Yamanishi, Christopher R Chapple, Kosaku Yasuda, et al.
Current Opinion in Urology|May 4, 2011
The afferent system and its role in lower urinary tract dysfunctionDonna M Daly, Valerie M Collins, Christopher R Chapple, et al.
Pageof 28